586 related articles for article (PubMed ID: 30771578)
21. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
[TBL] [Abstract][Full Text] [Related]
23. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
[TBL] [Abstract][Full Text] [Related]
24. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
25. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
26. The Cerebrospinal Fluid in Multiple Sclerosis.
Deisenhammer F; Zetterberg H; Fitzner B; Zettl UK
Front Immunol; 2019; 10():726. PubMed ID: 31031747
[TBL] [Abstract][Full Text] [Related]
27. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
[TBL] [Abstract][Full Text] [Related]
28. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
[TBL] [Abstract][Full Text] [Related]
29. Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases.
Lee EJ; Lim YM; Kim S; Choi L; Kim H; Kim K; Kim HW; Lee JS; Kim KK
Ann Clin Transl Neurol; 2020 Jun; 7(6):992-1001. PubMed ID: 32495489
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS.
Engel S; Friedrich M; Muthuraman M; Steffen F; Poplawski A; Groppa S; Bittner S; Zipp F; Luessi F
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454774
[TBL] [Abstract][Full Text] [Related]
31. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.
Arslan B; Ayhan Arslan G; Tuncer A; Karabudak R; Sepici Dinçel A
Bosn J Basic Med Sci; 2022 Sep; 22(5):699-706. PubMed ID: 35490364
[TBL] [Abstract][Full Text] [Related]
33. Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
Zelek WM; Watkins LM; Howell OW; Evans R; Loveless S; Robertson NP; Beenes M; Willems L; Brandwijk R; Morgan BP
Mult Scler; 2019 Apr; 25(4):523-531. PubMed ID: 29421990
[TBL] [Abstract][Full Text] [Related]
34. Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein.
Kim S; Lee JJ; Park JS; Kang M; Seok HY
Neurol Sci; 2024 Mar; 45(3):1255-1261. PubMed ID: 38141119
[TBL] [Abstract][Full Text] [Related]
35. Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.
Mariotto S; Farinazzo A; Magliozzi R; Alberti D; Monaco S; Ferrari S
J Peripher Nerv Syst; 2018 Sep; 23(3):174-177. PubMed ID: 29974556
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Martin SJ; McGlasson S; Hunt D; Overell J
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141
[TBL] [Abstract][Full Text] [Related]
37. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
[TBL] [Abstract][Full Text] [Related]
38. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
[TBL] [Abstract][Full Text] [Related]
40. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
